Back

Virtual screening identifies novel high-affinity σ1 receptor ligands

Schmidt, H. R.; Greenfield, D. A.; Sliz, P.; Kruse, A. C.

2019-07-11 pharmacology and toxicology
10.1101/699793 bioRxiv
Show abstract

The {sigma}1 receptor is a transmembrane protein implicated in several pathophysiological conditions, including neurodegenerative disease1, drug addiction2, cancer3, and pain4. However, there are no high-throughput functional assays for {sigma}1 receptor drug discovery. Here, we assessed high-throughput structure-based computational docking for discovery of novel ligands of the {sigma}1 receptor. We screened a library of over 6 million compounds using the Schrodinger Glide package, followed by experimental characterization of top-scoring candidates. 77% of tested candidates bound {sigma}1 with high affinity (10-550 nM). These include compounds with high selectivity for the {sigma}1 receptor compared to the genetically unrelated but pharmacologically similar {sigma}2 receptor, as well as compounds with substantial cross-reactivity between the two receptors. These results establish structure-based virtual screening as a highly effective platform for {sigma}1 receptor ligand discovery.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.